TAMPERE, Finland, and PHILADELPHIA, PA — Fimlab Laboratories, Finland’s largest laboratory services provider, is advancing its digital pathology capabilities by collaborating with Proscia, a renowned leader in AI-enabled pathology solutions. This partnership is set to enhance precision medicine by utilizing artificial intelligence to deliver more accurate diagnostic results.
Digital pathology is transforming the field by converting traditional glass slides into high-resolution digital images. These images, rich with intricate details, offer comprehensive insights into diseases such as cancer. Initially adopted for efficiency, digital pathology has evolved further with AI, which mines these data-rich images for valuable insights, driving advancements in precision medicine.
Dr. Teemu Tolonen, Chief Physician of Fimlab’s pathology department, highlights AI’s transformative potential: “Artificial intelligence is beginning to solve many of pathology’s biggest challenges.” After a thorough evaluation of available platforms, Fimlab selected Proscia’s software for its potential to significantly impact their operations. Proscia’s flexible, open architecture allows Fimlab to integrate a broad range of applications into their routine workflows.
Proscia’s platform is noted for its user-friendly interface, extensive functionality, and scalability. It enables pathologists at Fimlab to utilize AI-driven workflows, enhancing the consistency of interpretations across common cancer types and promoting operational efficiency. The platform supports a growing array of precision medicine applications, furthering Fimlab’s capabilities in pathology.
David West, CEO of Proscia, recognizes Fimlab as a trailblazer in the field. “Fimlab is one of the most innovative laboratories in the world. Its team is now advancing to the forefront of AI-enabled pathology with our software, and we are incredibly excited to see the impact of our work together.”
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.